Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: A metaanalysis of population-based prospective studies

European Journal of Cardiovascular Prevention & Rehabilitation

Volumn 3, Issue 2, 1996, Pages 213-219

  Hokanson, John E ^a   Austin, Melissa A ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Cardiovascular disease; Coronary heart disease; Epidemiology; High density lipoprotein cholesterol; Metaanalysis; Triglyceride

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; EUROPE; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; SCANDINAVIA; TRIACYLGLYCEROL BLOOD LEVEL; UNITED STATES;

ADOLESCENT; ADULT; AGED; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; TRIGLYCERIDES;

EID: 0029838433     PISSN: 17418267     EISSN: 17418275     Source Type: Journal    
DOI: 10.1177/174182679600300214     Document Type: Article

References (43)

1. Gofman J Strisower B deLalla O Tamplin A Jones H Lindgren F: Index of coronary artery atherogenesis Mod Med 1953, 21: 119-140.
2. Albrink MJ Man EB: Serum triglycerides in coronary artery disease Arch Intern Med 1959, 103: 4-8.
3. Brown DF Kinch SH Doyle JT: Serum triglycerides in health and in ischemic heart disease N Engl J Med 1965, 273: 947-952.
4. Austin MA: Plasma triglyceride and coronary heart disease Arterioscler Thromb 1991, 11: 2-14.
5. NIH Consensus Development Panel on Triglyceride, High Density Lipoprotein, and Coronary Heart Disease: Triglyceride, high density lipoprotein, and coronary heart disease JAMA 1993, 269: 505-510.
6. Criqui MH Heiss G Cohn R Cowan LD Suchindran CM Bangdiwala etal: Plasma triglyceride level and mortality from coronary heart disease N Engl J Med 1993, 328: 1220-1225.
7. Jacobs DR Jr Barrett-Connor E: Retest reliability of plasma cholesterol and triglyceride. The Lipid Research Clinics Prevalence Study Am J Epidemiol 1982, 116: 878-885.
8. Brenner H Heiss G: The intra individual variability of fasting triglyceride - a challenge for further standardization Eur Heart J 1990, 11: 1054-1058.
9. Phillips AN Smith GD: How independent are ‘independent’ effects? Relative risk estimation when correlated exposures are measured imprecisely J Clin Epidemiol 1991, 44: 1223-1231.
10. Greenland S: Quantitative methods in the review of epidemiologic literature Epidemiol Rev 1987, 9: 1-30.
11. Hulley SB Rosenman RH Bawol RD Brand RJ: Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease N Engl J Med 1980, 302: 1383-1389.
12. Rosenman RH Brand RJ Jenkins CD Friedman M Straus R Wurm M: Coronary heart disease in the Western Collaborative Group Study. Final follow-up experience of 8 1/2 years JAMA 1975, 233: 872-877.
13. Bottinger LE Carlson LA: Risk factors for death for males and females. A study of death pattern in the Stockholm Prospective Study Acta Med Scand 1982, 211: 437-442.
14. Wilhelmsen L Wedel H Tibblin G: Multivariate analysis of risk factors for coronary heart disease Circulation 1973, 48: 950-958.
15. Pelkonen R Nikkilä EA Koskinen S Penttinen K Sarna S: Association of serum lipids and obesity with cardiovascular mortality BMJ 1977, 2: 1185-1187.
16. Cambien F Jacqueson A Richard JL Warnet JM Ducimetiere P Claude JR: Is the level of serum triglyceride a significant predictor of coronary death in ‘normocholesterolemic’ subjects? The Paris Prospective Study Am J Epidemiol 1986, 124: 624-632.
17. Bengtsson C Bjorkelund C Lapidus L Lissner L: Association of serum lipid concentrations and obesity with mortality in women: 20 year follow-up of participants in prospective population study in Gothenburg, Sweden BMJ 1993, 307: 1385-1388.
18. Åberg H Lithell H Selinus I Hedstrand H: Serum triglycerides are a risk factor for myocardial infarction but not for angina pectoris. Results from a 10-year follow-up of Uppsala Primary Preventive Study Atherosclerosis 1985, 54: 89-97.
19. Wilson P Larson G Castelli W: Triglycerides, HDL-cholesterol and coronary artery disease: A Framingham update on the interactions Can J Cardiol 1994, 10 (Suppl B):5B-9B.
20. Salonen JT Puska P: Relation of serum cholesterol and triglycerides to the risk of acute myocardial infarction, cerebral stroke and death in eastern Finnish male population Int J Epidemiol 1983, 12: 26-31.
21. Heyden S Heiss G Hames CG Bartel AG: Fasting triglycerides as predictors of total and CHD mortality in Evans County, Georgia J Chron Dis 1980, 33: 275-282.
22. Glynn RJ Rosner B Silbert JE: Changes in cholesterol and triglyceride as predictors of Ischemic heart disease Circulation 1982, 66: 724-731.
23. Bainton D Miller NE Bolton CH Yarnell JWG Sweetnam PM Baker IA etal: Plasma triglyceride and high density lipoproteins cholesterol as predictors of ischaemic heart disease in British men. The Caerphilly and Speedwell Collaborative Heart Disease Studies Br Heart J 1992, 68: 60-66.
24. Sigurdsson G Baldursdottir Sigvaldason H Agnarsson U Thorgeirsson G Sigfusson N: Predictive value of apolipoproteins in a prospective survey of coronary artery disease in men Am J Cardiol 1992, 69: 1251-1254.
25. Assmann G Schulte H: Relation of high-density lipoprotein cholesterol and triglyceride to incidence of atherosclerotic coronary artery disease (the PROCAM experience) Am J Cardiol 1992, 70: 733-727.
26. Menotti A Spagnolo A Scanga M Dima F: Multivariate prediction of coronary disease deaths in a 10 year follow-up of an Italian occupational male cohort Acta Cardiologica 1992, 47: 311-320.
27. Menotti A Scanga M Morisi G: Serum triglycerides in the prediction of coronary artery disease (an Italian experience) Am J Cardiol 1994, 73: 29-32.
28. Austin MA King M.C. Vranizan KM Krauss RM: Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk Circulation 1990, 82: 495-506.
29. Reaven G: Role of insulin resistance in human disease Diabetes 1988, 37: 1595-1607.
30. Haffner SM Stern MP Hazuda HP Mitchell BD Patterson JK: Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 1990, 263: 2893-2898.
31. Mykkänen L Kuusisto J Pyörälä K Laakso M: Cardiovascular disease risk factors as predictors of type 2 (non-insuiin-dependent) diabetes mellitus in elderly subjects Diabetologia 1993, 36: 4553-4559.
32. Edwards KL Austin MA Newman B Mayer E Krauss RM Selby JV: Multivariate analysis of the insulin resistance syndrome Arterioscler Thromb 1994, 14: 1940-1945.
33. Hedges LV Olkin I: Statistical Methods for Meta-analysis. New York: Academic Press; 1984.
34. Manninen V Tenkanen L Koskinen P Mänttäri M Heinonen OP etal: Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment Circulation 1992, 85: 37-45.
35. Rhoads GG Feinleib M: Serum triglyceride and risk of coronary heart disease, stroke, and total mortality in Japanese-American men Arteriosclerosis 1983, 3: 316-322.
36. Patsch JR Miesenböck G Hopferwieser T Mühlberger V Knapp E Dunn JK etal: Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state Arterioscler Thromb 1992, 12: 1336-1345.
37. Karpe F Steiner G Uffelman K Olivercrona T Hamsten A: Postprandial lipoproteins and progression of coronary atherosclerosis Atherosclerosis 1994, 106: 83-97.
38. Hodis HN Mack WJ Azen SP Alaupovic P Pogoda JM LaBree L etal: Triglyceride- and cholesterol-risk lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatain Circulation 1994, 90: 42-19.
39. Dalaker K Hjermann I Prydz H: A novel form of factor VII in plasma from men at risk for cardiovascular disease Br J Haematol 1985, 61: 315-322.
40. Hamsten A De Faire U Walldius G Dahlen G Szamosi A Landou C etal: Plasminogen activator inhibitor in plasma: Risk factor for recurrent myocardial infarction Lancet 1987, 2: 3-9.
41. Gianturco SH Bradley WA: Lipoprotein-mediated cellular mechanism for atherogenesis in hypertriglyceridemia Sem Thromb Hemostasis 1988, 14: 165-169.
42. Study Group of the European Atherosclerosis Society: The recognition and management of hyperlipidaemia in adults. A policy statement of the European Atherosclerosis Society Eur Heart J 1988, 9: 571-600.
43. Expert panel on detection, evaluation, and treatment of high cholesterol in adults (Adult Treatment Panel II): Summary of the second report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high cholesterol in adults (Adult Treatment Panel II) JAMA 1993, 269: 3015-2023.